Inactivated influenza virus compositions
AssigneesThe United States of America, as represented by the Secretary, Department of Health and Human Services, University of Georgia Research Foundation, Inc.
InventorsYossef Raviv, Mathias Viard, Robert Blumenthal, Robert J. Hogan, Stephen Mark Tompkins
Life of this patent
Estimating the term…
Abstract
The invention provides compositions of inactivated influenza virus that can be used as vaccines and immunological compositions useful for inhibiting, preventing and treating influenza.
Claims5
A method of inactivating an influenza virus comprising contacting the influenza virus with an effective amount of 1,5-iodonaphthylazide to form a mixture of the influenza virus and the 1,5-iodonaphthylazide, and exposing the mixture to light, optionally with an effective amount of a photo sensitizer chromophore, for a time sufficient to generate the inactivated influenza virus.
Dependencies are inferred from the claim text.